Call: +7 771 977 66 65, +7 705 421 2277
Sign in or Register
My basket

Astana Biomed Group, an authorized Abcam distributor in Central Asia

Abiomed homepage

  • Categories
    Signal Transduction
    Cancer
    Epigenetics and Nuclear Signaling
    Immunology
    Cell Biology
    Cardiovascular
    Neuroscience
    Tags & Cell Markers
    Kits/ Lysates/ Other
    Developmental Biology
    Microbiology
    Biochemicals
    Secondary antibodies
    Isotype/Loading Controls
    Antibody Arrays
  • About us
  • Partners
  • Contact
    Address

    Saryarka 32, 18, 010000, Astana city, Kazakhstan

    Telephone +7 771 977 66 65, +7 705 421 2277

    Email

    laboratory@ctlab.kz, orders@abiomed.kz

Back to category
Signal Transduction Protein Trafficking Organelle Proteins

Anti-Caveolin-3 antibody - Caveolae Marker (ab30750)

Price and availability

288 134 ₸

Availability

Order now and get it on Wednesday February 24, 2021

Anti-Caveolin-3 antibody - Caveolae Marker (ab30750)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)

Key features and details

  • Rabbit polyclonal to Caveolin-3 - Caveolae Marker
  • Suitable for: IP, ICC/IF, WB
  • Reacts with: Mouse, Rat, Human
  • Isotype: IgG

You may also be interested in

Product image
Human GOLPH2 ELISA Kit (ab277428)
Product image
Anti-MTX1/MTX antibody (ab233205)
Product image
Anti-EHD4 antibody [EPR9816(B)] - BSA and Azide free (ab249018)
Product image
Human ATP5J2 knockout HEK-293T cell lysate (ab258789)

Overview

  • Product name

    Anti-Caveolin-3 antibody - Caveolae Marker
    See all Caveolin-3 primary antibodies
  • Description

    Rabbit polyclonal to Caveolin-3 - Caveolae Marker
  • Host species

    Rabbit
  • Tested applications

    Suitable for: IP, ICC/IF, WBmore details
  • Species reactivity

    Reacts with: Mouse, Rat, Human
  • Immunogen

    Synthetic peptide corresponding to Human Caveolin-3 aa 1-100 conjugated to keyhole limpet haemocyanin.
    (Peptide available as ab31791)

Properties

  • Form

    Liquid
  • Storage instructions

    Shipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C or -80°C. Avoid freeze / thaw cycle.
  • Storage buffer

    pH: 7.40
    Preservative: 0.02% Sodium azide
    Constituent: PBS

    Batches of this product that have a concentration
  • Concentration information loading...
  • Purity

    Immunogen affinity purified
  • Clonality

    Polyclonal
  • Isotype

    IgG
  • Research areas

    • Signal Transduction
    • Protein Trafficking
    • Organelle Proteins
    • Signal Transduction
    • Metabolism
    • Plasma Membrane
    • Channels
    • Tags & Cell Markers
    • Subcellular Markers
    • Organelles
    • Caveolae and Clathrin
    • Signal Transduction
    • Protein Trafficking
    • Golgi Proteins
    • Signal Transduction
    • Metabolism
    • Vitamins / Minerals
    • Cardiovascular
    • Heart
    • Cardiac metabolism
    • Cardiovascular
    • Heart
    • Hypertrophy
    • Other
    • Developmental Biology
    • Organogenesis
    • Skeletal development
    • Muscle

Associated products

  • Compatible Secondaries

    • Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) (ab150077)
    • Goat Anti-Rabbit IgG H&L (HRP) (ab205718)
  • Isotype control

    • Rabbit IgG, polyclonal - Isotype Control (ChIP Grade) (ab171870)
  • Recombinant Protein

    • Recombinant Human Caveolin-3 protein (ab114265)

Applications

Our Abpromise guarantee covers the use of ab30750 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
IP Use at an assay dependent concentration.
ICC/IF Use a concentration of 5 µg/ml.
WB Use a concentration of 1 µg/ml. Detects a band of approximately 18 kDa (predicted molecular weight: 17 kDa).

Target

  • Function

    May act as a scaffolding protein within caveolar membranes. Interacts directly with G-protein alpha subunits and can functionally regulate their activity. May also regulate voltage-gated potassium channels. Plays a role in the sarcolemma repair mechanism of both skeletal muscle and cardiomyocytes that permits rapid resealing of membranes disrupted by mechanical stress.
  • Tissue specificity

    Expressed predominantly in muscle.
  • Involvement in disease

    Defects in CAV3 are the cause of limb-girdle muscular dystrophy type 1C (LGMD1C) [MIM:607801]. LGMD1C is a myopathy characterized by calf hypertrophy and mild to moderate proximal muscle weakness. LGMD1C inheritance can be autosomal dominant or recessive.
    Defects in CAV3 are a cause of hyperCKmia (HYPCK) [MIM:123320]. It is a disease characterized by persistent elevated levels of serum creatine kinase without muscle weakness.
    Defects in CAV3 are a cause of rippling muscle disease (RMD) [MIM:606072]. RMD is a rare disorder characterized by mechanically triggered contractions of skeletal muscle. In RMD, mechanical stimulation leads to electrically silent muscle contractions that spread to neighboring fibers that cause visible ripples to move over the muscle.
    Defects in CAV3 are a cause of cardiomyopathy familial hypertrophic (CMH) [MIM:192600]; also designated FHC or HCM. Familial hypertrophic cardiomyopathy is a hereditary heart disorder characterized by ventricular hypertrophy, which is usually asymmetric and often involves the interventricular septum. The symptoms include dyspnea, syncope, collapse, palpitations, and chest pain. They can be readily provoked by exercise. The disorder has inter- and intrafamilial variability ranging from benign to malignant forms with high risk of cardiac failure and sudden cardiac death.
    Defects in CAV3 are the cause of long QT syndrome type 9 (LQT9) [MIM:611818]. Long QT syndromes are heart disorders characterized by a prolonged QT interval on the ECG and polymorphic ventricular arrhythmias. They cause syncope and sudden death in response to excercise or emotional stress. They can present with a sentinel event of sudden cardiac death in infancy.
    Defects in CAV3 can be a cause of sudden infant death syndrome (SIDS) [MIM:272120]. SIDS is the sudden death of an infant younger than 1 year that remains unexplained after a thorough case investigation, including performance of a complete autopsy, examination of the death scene, and review of clinical history. Pathophysiologic mechanisms for SIDS may include respiratory dysfunction, cardiac dysrhythmias, cardiorespiratory instability, and inborn errors of metabolism, but definitive pathogenic mechanisms precipitating an infant sudden death remain elusive. Long QT syndromes-associated mutations can be responsible for some SIDS cases.
  • Sequence similarities

    Belongs to the caveolin family.
  • Cellular localization

    Golgi apparatus membrane. Cell membrane. Membrane > caveola. Potential hairpin-like structure in the membrane. Membrane protein of caveolae.
  • Target information above from: UniProt accession P56539 The UniProt Consortium
    The Universal Protein Resource (UniProt) in 2010
    Nucleic Acids Res. 38:D142-D148 (2010) .

    Information by UniProt
  • Database links

    • Entrez Gene: 859 Human
    • Entrez Gene: 12391 Mouse
    • Entrez Gene: 29161 Rat
    • Omim: 601253 Human
    • SwissProt: P56539 Human
    • SwissProt: P51637 Mouse
    • SwissProt: P51638 Rat
    • Unigene: 98303 Human
    • Unigene: 3924 Mouse
    • Unigene: 98191 Rat
    see all
  • Alternative names

    • CAV3 antibody
    • CAV3_HUMAN antibody
    • Caveolin 3 antibody
    • Caveolin-3 antibody
    • LGMD1C antibody
    • LQT9 antibody
    • M-caveolin antibody
    • MGC126100 antibody
    • MGC126101 antibody
    • MGC126129 antibody
    • OTTHUMP00000115603 antibody
    • OTTHUMP00000207105 antibody
    • VIP 21 antibody
    • VIP21 antibody
    see all

Images

  • Western blot - Anti-Caveolin-3 antibody - Caveolae Marker (ab30750)
    Western blot - Anti-Caveolin-3 antibody - Caveolae Marker (ab30750)
    All lanes : Anti-Caveolin-3 antibody - Caveolae Marker (ab30750) at 1 µg/ml

    Lane 1 : Human skeletal muscle tissue lysate - total protein (ab29330)
    Lane 2 : Human heart tissue lysate - total protein (ab29431)
    Lane 3 : Mouse skeletal muscle tissue lysate - total protein (ab29711)
    Lane 4 : Skeletal Muscle (Rat) Tissue Lysate - normal tissue (ab29376)

    Lysates/proteins at 20 µg per lane.

    Secondary
    All lanes : IRDye 680 Conjugated Goat Anti-Rabbit IgG (H+L) at 1/10000 dilution

    Performed under reducing conditions.

    Predicted band size: 17 kDa
    Observed band size: 17 kDa
    Additional bands at: 40 kDa. We are unsure as to the identity of these extra bands.

  • Immunocytochemistry/ Immunofluorescence - Anti-Caveolin-3 antibody - Caveolae Marker (ab30750)
    Immunocytochemistry/ Immunofluorescence - Anti-Caveolin-3 antibody - Caveolae Marker (ab30750)
    ICC/IF image of ab30750 stained HepG2 cells. The cells were 100% methanol fixed (5 min) and then incubated in 1%BSA / 10% normal goat serum / 0.3M glycine in 0.1% PBS-Tween for 1h to permeabilise the cells and block non-specific protein-protein interactions. The cells were then incubated with the antibody (ab30750, 5µg/ml) overnight at +4°C. The secondary antibody (green) was ab96899 Dylight® 488 goat anti-rabbit IgG (H+L) used at a 1/250 dilution for 1h. Alexa Fluor® 594 WGA was used to label plasma membranes (red) at a 1/200 dilution for 1h. DAPI was used to stain the cell nuclei (blue) at a concentration of 1.43µM.

  • Immunoprecipitation - Anti-Caveolin-3 antibody - Caveolae Marker (ab30750)
    Immunoprecipitation - Anti-Caveolin-3 antibody - Caveolae Marker (ab30750)
    Caveolin 3 - Caveolae Marker was immunoprecipitated using 0.5mg Mouse skeletal muscle whole tissue extract, 5µg of Rabbit polyclonal to Caveolin 3 and 50µl of protein G magnetic beads (+). No antibody was added to the control (-).
    The antibody was incubated under agitation with Protein G beads for 10min, Mouse skeletal muscle whole tissue extract lysate diluted in RIPA buffer was added to each sample and incubated for a further 10min under agitation.
    Proteins were eluted by addition of 40µl SDS loading buffer and incubated for 10min at 70oC; 10µl of each sample was separated on a SDS PAGE gel, transferred to a nitrocellulose membrane, blocked with 5% BSA and probed with ab30750.
    Secondary: Clean blot (HRP conjugate) at 1/1000 dilution.
    Band: 17kDa: Caveolin 3 - Caveolae Marker.

Protocols

  • Immunoprecipitation protocols
  • Immunocytochemistry & immunofluorescence protocols
  • Western blot protocols

Click here to view the general protocols

Datasheets and documents

    • Datasheet
  • References (3)

    Publishing research using ab30750? Please let us know so that we can cite the reference in this datasheet.

    ab30750 has been referenced in 3 publications.

    • Fujiwara D  et al. SIRT1 deficiency interferes with membrane resealing after cell membrane injury. PLoS One 14:e0218329 (2019). PubMed: 31242212
    • Valentine CD & Haggie PM Confinement of ß(1)- and ß(2)-adrenergic receptors in the plasma membrane of cardiomyocyte-like H9c2 cells is mediated by selective interactions with PDZ domain and A-kinase anchoring proteins but not caveolae. Mol Biol Cell 22:2970-82 (2011). PubMed: 21680711
    • Willett M  et al. Inhibition of mammalian target of rapamycin (mTOR) signalling in C2C12 myoblasts prevents myogenic differentiation without affecting the hyperphosphorylation of 4E-BP1. Cell Signal 21:1504-12 (2009). PubMed: 19481146

    Images

    • Western blot - Anti-Caveolin-3 antibody - Caveolae Marker (ab30750)
      Western blot - Anti-Caveolin-3 antibody - Caveolae Marker (ab30750)
      All lanes : Anti-Caveolin-3 antibody - Caveolae Marker (ab30750) at 1 µg/ml

      Lane 1 : Human skeletal muscle tissue lysate - total protein (ab29330)
      Lane 2 : Human heart tissue lysate - total protein (ab29431)
      Lane 3 : Mouse skeletal muscle tissue lysate - total protein (ab29711)
      Lane 4 : Skeletal Muscle (Rat) Tissue Lysate - normal tissue (ab29376)

      Lysates/proteins at 20 µg per lane.

      Secondary
      All lanes : IRDye 680 Conjugated Goat Anti-Rabbit IgG (H+L) at 1/10000 dilution

      Performed under reducing conditions.

      Predicted band size: 17 kDa
      Observed band size: 17 kDa
      Additional bands at: 40 kDa. We are unsure as to the identity of these extra bands.

    • Immunocytochemistry/ Immunofluorescence - Anti-Caveolin-3 antibody - Caveolae Marker (ab30750)
      Immunocytochemistry/ Immunofluorescence - Anti-Caveolin-3 antibody - Caveolae Marker (ab30750)
      ICC/IF image of ab30750 stained HepG2 cells. The cells were 100% methanol fixed (5 min) and then incubated in 1%BSA / 10% normal goat serum / 0.3M glycine in 0.1% PBS-Tween for 1h to permeabilise the cells and block non-specific protein-protein interactions. The cells were then incubated with the antibody (ab30750, 5µg/ml) overnight at +4°C. The secondary antibody (green) was ab96899 Dylight® 488 goat anti-rabbit IgG (H+L) used at a 1/250 dilution for 1h. Alexa Fluor® 594 WGA was used to label plasma membranes (red) at a 1/200 dilution for 1h. DAPI was used to stain the cell nuclei (blue) at a concentration of 1.43µM.

    • Immunoprecipitation - Anti-Caveolin-3 antibody - Caveolae Marker (ab30750)
      Immunoprecipitation - Anti-Caveolin-3 antibody - Caveolae Marker (ab30750)
      Caveolin 3 - Caveolae Marker was immunoprecipitated using 0.5mg Mouse skeletal muscle whole tissue extract, 5µg of Rabbit polyclonal to Caveolin 3 and 50µl of protein G magnetic beads (+). No antibody was added to the control (-).
      The antibody was incubated under agitation with Protein G beads for 10min, Mouse skeletal muscle whole tissue extract lysate diluted in RIPA buffer was added to each sample and incubated for a further 10min under agitation.
      Proteins were eluted by addition of 40µl SDS loading buffer and incubated for 10min at 70oC; 10µl of each sample was separated on a SDS PAGE gel, transferred to a nitrocellulose membrane, blocked with 5% BSA and probed with ab30750.
      Secondary: Clean blot (HRP conjugate) at 1/1000 dilution.
      Band: 17kDa: Caveolin 3 - Caveolae Marker.

    Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES"
    For licensing inquiries, please contact partnerships@abcam.com

    Alternative products to Anti-Caveolin-3 antibody - Caveolae Marker (ab30750)

    •  
    • Product image

      Anti-Caveolin-3 antibody [EPR18975] (ab182739)

      Applications: IHC-P, IP, WB

    •  
    • Product image

      Anti-Caveolin-3 antibody - Caveolae Marker (ab2912)

      Applications: Flow Cyt, ICC/IF, IHC-P, IP, WB

    •  
    • Product image

      Anti-Caveolin-3 antibody (ab87770)

      Applications: IHC-P, WB

    •  
    • Product image

      Anti-Caveolin-3 antibody [EPR11082] (ab173575)

      Applications: ICC/IF, IHC-FoFr, IHC-P, WB

    •  
    • Product image

      Anti-Caveolin-3 antibody (ab217530)

      Applications: IHC-P

    •  
    • Product image

      Anti-Caveolin-3 antibody - N-terminal (ab189349)

      Applications: IHC-P, WB

    •  
    • Product image

      Anti-Caveolin-3 antibody [C3B0] (ab238510)

      Applications: WB

    •  
    • Product image

      Anti-Caveolin-3 antibody [EPR11083] (ab171752)

      Applications: IHC-P, IP, WB

    Clear all

    Recently viewed products

    •  
    • Product image

      Anti-Ubiquitin (linkage-specific K27) antibody [EPR17034] (ab181537)

    •  
    • Product image

      Anti-RKIP (phospho S153) antibody [EP2845Y] (ab75971)

    •  
    • Product image

      Anti-PIGK antibody [EPR17843] - BSA and Azide free (ab251354)

    •  
    • Product image

      Anti-BRCA1 antibody - C-terminal (ab191042)

    •  
    • Product image

      Anti-UBA5 antibody [EPR11729] - BSA and Azide free (ab249983)

    •  
    • Product image

      Anti-beta Catenin antibody [CTNNB1/2098] (ab237982)

    Get resources and offers direct to your inbox Sign up
    © 2021 Astana Biomed Group LLP. All rights reserved.